0001213900-19-013481.txt : 20190724 0001213900-19-013481.hdr.sgml : 20190724 20190724170102 ACCESSION NUMBER: 0001213900-19-013481 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20190724 DATE AS OF CHANGE: 20190724 GROUP MEMBERS: JAMES C. ELBAOR GROUP MEMBERS: MARLTON WAYNE GP, LP GROUP MEMBERS: MARLTON, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PARKS AMERICA, INC CENTRAL INDEX KEY: 0001297937 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION [7990] IRS NUMBER: 910626756 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81730 FILM NUMBER: 19971638 BUSINESS ADDRESS: STREET 1: 1300 OAK GROVE RD CITY: PINE MOUNTAIN STATE: GA ZIP: 31822 BUSINESS PHONE: 706-663-8744 MAIL ADDRESS: STREET 1: 1300 OAK GROVE RD CITY: PINE MOUNTAIN STATE: GA ZIP: 31822 FORMER COMPANY: FORMER CONFORMED NAME: GREAT AMERICAN FAMILY PARKS INC DATE OF NAME CHANGE: 20040721 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Marlton Wayne, LP CENTRAL INDEX KEY: 0001730066 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 222 WEST MERCHANDISE MART PLAZA STREET 2: SUITE 1212 CITY: CHICAGO STATE: IL ZIP: 60654 BUSINESS PHONE: (214) 405-4141 MAIL ADDRESS: STREET 1: 222 WEST MERCHANDISE MART PLAZA STREET 2: SUITE 1212 CITY: CHICAGO STATE: IL ZIP: 60654 SC 13D/A 1 sc13d0719a3marlton_parks.htm AMENDMENT NO. 3 TO SCHEDULE 13D

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No. 3)1

Parks! America, Inc.

(Name of Issuer)

Common Shares, no par value

(Title of Class of Securities)

701455107

(CUSIP Number)

 

MARLTON WAYNE, LP

222 W Merchandise Mart Plaza

Suite 1212

Chicago, Illinois 60554

(312) 204-7288

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

July 22, 2019

(Date of Event Which Requires Filing of This Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

 

 
1The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP NO. 701455107

  1   NAME OF REPORTING PERSON  
         
        Marlton Wayne, LP  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☒
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        WC  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        Delaware, United States of America  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         3,768,179  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          3,768,179  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        3,768,179  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        5.04%*  
  14   TYPE OF REPORTING PERSON  
         
        PN  

 

*Based upon 74,821,537 shares of common stock outstanding as of May 1, 2019, as disclosed in its Form 10-Q that was filed on May 2, 2019, by the Issuer with the Securities and Exchange Commission.

 

2

CUSIP NO. 701455107

  1   NAME OF REPORTING PERSON  
         
        James C. Elbaor  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☒
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        OO  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        United States of America  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         3,768,179  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          3,768,179  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        3,768,179  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        5.04%*  
  14   TYPE OF REPORTING PERSON  
         
        IN, HC  

 

*Based upon 74,821,537 shares of common stock outstanding as of May 1, 2019, as disclosed in its Form 10-Q that was filed on May 2, 2019, by the Issuer with the Securities and Exchange Commission.

 

3

CUSIP NO. 701455107

  1   NAME OF REPORTING PERSON  
         
        Marlton Wayne GP, LP  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☒
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        OO  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        Delaware, United States of America  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         3,768,179  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          3,768,179  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        3,768,179  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        5.04%*  
  14   TYPE OF REPORTING PERSON  
         
        PN, HC  

 

*Based upon 74,821,537 shares of common stock outstanding as of May 1, 2019, as disclosed in its Form 10-Q that was filed on May 2, 2019, by the Issuer with the Securities and Exchange Commission.

 

4

CUSIP NO. 701455107

  1   NAME OF REPORTING PERSON  
         
        Marlton, LLC  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☒
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        OO  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        Delaware, United States of America  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         3,768,179  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          3,768,179  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        3,768,179  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        5.04%*  
  14   TYPE OF REPORTING PERSON  
         
        HC, IA  

 

*Based upon 74,821,537 shares of common stock outstanding as of May 1, 2019, as disclosed in its Form 10-Q that was filed on May 2, 2019, by the Issuer with the Securities and Exchange Commission.

 

5

CUSIP NO. 701455107

The following constitutes Amendment No. 3 to the Schedule 13D filed by the undersigned (“Amendment No. 3”). This Amendment No. 3 amends the Schedule 13D as specifically set forth herein.

Item 4.Purpose of Transaction.

 

Item 4 is hereby amended to add the following:

 

On July 22, 2019, Marlton Wayne, L.P. (“Marlton Wayne”) delivered a letter to the Issuer (the “Request”) demanding the inspection of certain of the Issuer’s books and records pursuant to the Issuer’s bylaws, NRS Chapter 78 and other applicable law pertaining to, among other things, the Issuer’s (i) accounting records from the time it retained Tama, Budaj & Raab, P.C., (ii) records concerning the use, selection and/or retention of Tama, Budaj & Raab, P.C., and (iii) communications with and documents provided to or received from Tama, Budaj & Raab, P.C. The Request also stated that, for reasons explained in the Request, PRKA’s value has been compromised by the Issuer’s decision to use Tama, Budaj & Raab, P.C.

 

The foregoing description of the Request does not purport to be complete and is qualified in its entirety by reference to the full text of the letter, which is filed as Exhibit 99.1, and is incorporated herein by reference.

 

Item 7.Material to be Filed as Exhibits.

 

Item 7 is hereby amended to add the following exhibit:

99.1Books and Records request dated  July 22, 2019

 

6

 

 

SIGNATURES

After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: July 24, 2019

 

  Marlton Wayne, LP
   
  By: Marlton Wayne GP, LP, its general partner
  By: Marlton, LLC, general partner of Marlton Wayne GP, LP
     
  By:

/s/ James C. Elbaor

    Name: James C. Elbaor
    Title: Sole Member

 

  Marlton Wayne GP, LP
   
  By: Marlton, LLC, its general partner
     
  By:

/s/ James C. Elbaor

    Name: James C. Elbaor
    Title: Sole Member

 

  Marlton, LLC
   
  By:

/s/ James C. Elbaor

    Name: James C. Elbaor
    Title: Sole Member

 

 

/s/ James C. Elbaor

  James C. Elbaor

 

 

7

 

 

EX-99.1 2 sc13d0719a3ex99-1marlton_pa.htm BOOKS AND RECORDS REQUEST DATED JULY 22, 2019

Exhibit 99.1

 

Marlton Wayne, L.P.

222 West Merchandise Mart Plaza, 1212

Chicago, Illinois 60654

Tel: (312) 204-7288

 

July 22, 2019

 

Via Overnight Courier

 

The Board of Directors

Parks! America, Inc.

1300 Oak Grove Road

Pine Mountain, GA 31822

 

Via Personal Service

 

Parks! America, Inc.

c/o Nevada Agency and Transfer Company, its registered agent

50 West Liberty Street, Suite 880

Reno, Nevada 89501

 

RE: Demand to Inspect Books and Records

 

To: PARKS! AMERICA, INC.

 

I, James C. Elbaor, am the sole member of Marlton, LLC, which is the general partner of Marlton Wayne GP, LP, which is the general partner of Marlton Wayne, LP. Marlton Wayne, LP, is a stockholder of more than five percent of the outstanding shares of Parks! America, Inc. (“PRKA” or “Company”), a Nevada corporation with its principal office in Pine Mountain, Georgia.

 

Pursuant to PRKA’s Bylaws, NRS Chapter 78, and other applicable law (including the common law), I hereby demand that PRKA allow me to inspect and copy the following PRKA books and records on July 29, 2019:

 

1.The minutes of all stockholders, Board, and Committee meetings, and records of all actions taken by the stockholders, the Board, or a Committee without a meeting. To be clear, this includes the minutes of the Audit Committee;

 

2.All financial statements for the past three (3) years;

 

3.All written communications made to the stockholders within the last three (3) years;

 

4.A register of names and business addresses of each stockholder, director, and officer;

 

5.The last three (3) annual reports; and

 

6.The stock transfer books of the Company, as described in the Bylaws, Section 2.7.

 

 

 

 

In addition the foregoing records, Marlton also demands to inspect the following:

 

7.All Company’s accounting records, from the time it retained Tama, Budaj & Raab, P.C., as its independent auditor to the present;

 

8.All records concerning the use, selection, and/or retention of Tama, Budaj & Raab, P.C., as the Company’s independent auditor;

 

9.All communications with and documents provided to and/or received from Tama, Budaj & Raab, P.C., in connection with its audits of the Company’s financial statements; and

 

10.The Audit Committee Charter.

 

The purpose of this demand is to permit me to review the requested records for lawful purposes reasonably related to Marlton’s interest as a PRKA stockholder. I have not demanded the inspection for a purpose that is in the interest of a business or object other than the business of the Company; nor have I demanded the inspection for any purpose not related to Marlton’s interest in PRKA as a stockholder. I have not at any time sold or offered for sale any list of stockholders of any domestic or foreign corporation or aided or abetted any person in procuring any such record of stockholders for any such purpose. I have instead demanded the inspection for a purpose reasonably related to Marlton’s interests as a stockholder of PRKA. I have enclosed my affidavit attesting to the foregoing.

 

That said, under the Bylaws, Sections 10.1 and 10.2(a), Marlton has an absolute right to inspect and copy, during regular business hours at the Company’s principal office, the records identified by #s 1–6, above. Stated differently, I do not need to identify any purpose for the inspection of records #s 1–6 that is related to Marlton’s interests as a PRKA stockholder, so long as I give written notice of inspection at least five business days before the date of inspection. This letter constitutes timely demand. Nevertheless, I describe the purpose, including for the records identified by #s 7–10.

 

PRKA’s value, as whole, and the value of my shares, derivatively, have been compromised by the directors’ decision to use Tama, Budaj & Raab, P.C., as the Company’s independent auditor. The PCAOB issued a Report on Tama. That Report revealed that Tama had one public company client at the time: PRKA. Given the one client, the Report examined Tama’s audit of PRKA.

 

A careful look at the PCAOB Report (,which I enclose for your reference,) highlights several disturbing facts about Tama’s inability to conduct a proper audit, which, in turn, raises serious questions about the integrity of the Company’s financial statements and the directors’ fulfillment of their fiduciary duties. I am entitled to investigate both the value of Marlton’s shares and director mismanagement in relation to these issues.

 

2

 

 

The Report established that, at the time Tama issued its audit report, Tama had not obtained sufficient appropriate evidence or reasonable assurance to support its opinion that PRKA’s financial statements were free of material misstatements. In particular, Tama’s audit failed to perform sufficient procedures to test journal entries and expenses in response to the risks of management override of controls, which directly violated PCAOB auditing standards (AS 2301.13; AS 2401.61; and AS 2810.03-04). Worse, the Report highlights that Tama’s auditing failures could also relate to violations of other applicable provisions of the auditing standards, including those concerning due professional care, responses to risk assessments, and audit evidence (AS 1015.02 and .05-.09; AS 1105.04; AS 2301.03, .05, and .07-.08).

 

In sum, the Report determined that Tama’s auditing failures were serious and that Tama’s audit opinion should not have been issued.

 

Despite the PCAOB’s findings in November 2018, PRKA continued to use Tama to issue its annual report and associated financial statements filed with the SEC in December 2018. PRKA’s decisions, at the very least, raise serious questions about the integrity of the Company’s financial statements and the Company’s value and the derivative value of Marlton’s shares.

 

They also raise serious questions about the functioning of the Company’s Audit Committee, on which the following directors sit: Dale Van Voorhis (also CEO), Charles Kohnen, and Jeffery Lococo (also Secretary). As Audit Committee members, these individuals are directly responsible for overseeing the Company’s internal controls, audits, and independent auditor. They have failed in all these respects.

 

Accordingly, Marlton has invoked its rights to inspect the Company’s books and records, as demanded in this letter.

 

Marlton also invokes its rights under the Bylaws, Section 10.3(b), to obtain copies of the demanded records in electronic form, if available. Marlton agrees to pay for the reasonable costs of labor and materials used to produce the copies; please forward an estimated cost of producing or reproducing the records, as the charges may not exceed the estimate.

 

I have designated Marlton’s attorney, Ballard Spahr LLP, and its employees, representatives, agents, and other persons designated by it to conduct the requested inspection. Enclosed is a Power of Attorney appointing such persons as Marlton’s attorney-in-fact.

 

I demand that PRKA provide Marlton the demanded records by July 29, 2019, which is at least five (5) business days from the date of this demand by forwarding copies of the records to:

 

Maria A. Gall, Esq.

Ballard Spahr LLP

1980 Festival Plaza Drive, Suite 900

Las Vegas, Nevada 89138

(702) 868-7535

gallm@ballardspahr.com

  

[Remainder Of Page Left Intentionally Blank]

 

3

 

 

Marlton reserves all its rights to enforce this demand and seek its damages should you choose not to comply and deny Marlton its stockholder rights. If you have any questions about this demand, you may contact my attorney at the above phone number and/or email.

 

Sincerely,

 

 /s/ James C. Elbaor

 

James C. Elbaor

 

Enclosures

  

4